drugset
drugset / Trial / NCT04762082

A Single Dose Randomized Five-Way Crossover Pharmacokinetics (PK) Study of Tadalafil Semi-Chewable (Gummy) Formulations in Healthy Volunteers

NCT04762082 ↗

Phase 1 Unknown 30 enrolled Seattle Gummy Company
RandomizedCrossoverOpen-labelTreatment

Summary

This is a randomized, open-label, single-dose, five-period crossover, relative bioavailability study to evaluate tadalafil gummy 10mg and tadalafil oral tablets 10mg in healthy volunteers

Timeline

Start
2025-05-01
Primary completion
2025-08-30
Completion
2025-12-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Tadalafil Small molecule 10 mg Oral

Indications

erectile dysfunction